Carl P. Sherr & Co’s Pfizer PFE Stock Holding History

Carl P. Sherr & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,778	Closed	-$324K	–	120
2023 Q3	$324K	Buy	9,778 +1,325	+16%	+$46.9K	0.22%	88
2023 Q2	$310K	Buy	8,453 +1,710	+25%	+$66.6K	0.2%	91
2023 Q1	$275K	Sell	6,743 -55	-0.8%	-$2.38K	0.2%	95
2022 Q4	$348K	Sell	6,798 -613	-8%	-$29.4K	0.26%	81
2022 Q3	$324K	Buy	7,411 +1,213	+20%	+$58.9K	0.26%	83
2022 Q2	$325K	Hold	6,198	–	–	0.24%	89
2022 Q1	$321K	Sell	6,198 -27	-0.4%	-$1.4K	0.22%	96
2021 Q4	$368K	Buy	+6,225	New	+$308K	0.22%	92
2021 Q3	–	Sell	-6,143	Closed	-$241K	–	114
2021 Q2	$241K	Sell	6,143 -3,015	-33%	-$117K	0.17%	107
2021 Q1	$332K	Sell	9,158 -10,117	-52%	-$359K	0.25%	91
2020 Q4	$710K	Sell	19,275 -1,719	-8%	-$63.1K	0.57%	51
2020 Q3	$731K	Sell	20,994 -454	-2%	-$15.9K	0.66%	44
2020 Q2	$665K	Sell	21,448 -385	-2%	-$13.1K	0.66%	48
2020 Q1	$676K	Sell	21,833 -1,311	-6%	-$44.7K	0.8%	38
2019 Q4	$860K	Buy	+23,144	New	+$824K	0.84%	43

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Carl P. Sherr & Co's PFE Position: Q4 2023 in Review

Carl P. Sherr & Co sold out of Pfizer (PFE) in Q4 2023, closing a stake of 9,778 shares — an estimated $324K sold.

Carl P. Sherr & Co first reported a position in PFE in Q4 2019 and held it in 15 quarters. The position peaked at $860K in Q4 2019. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Carl P. Sherr & Co reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Carl P. Sherr & Co sold 9,778 Pfizer shares in Q4 2023, an estimated $324K.
Carl P. Sherr & Co first reported a position in Pfizer in Q4 2019 and held it in 15 quarters.
Carl P. Sherr & Co's Pfizer position peaked at $860K in Q4 2019.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Carl P. Sherr & Co's 13F filing for Q4 2023, filed 30 Jan 2024.